You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DFTX Sale Disclosure
Barrow Robert · SEC Form 4 · Filed Sep 4, 2026
Sale
Calculated transaction value
$721.73K
Barrow Robert Chief Executive Officer
DFTX
Transaction date
Sep 3, 2026
Public filing date
Sep 4, 2026
Filing lag
Filed 1 day later
DFTX daily price context
Close on/before transaction
$38
Sep 3, 2026
First close after public filing
$38.23
Sep 8, 2026
30-day return after filing
-5.23%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 19,023 shares @ $37.94
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-384042
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$721.73K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Definium Therapeutics, Inc. DFTX Current | Sale | Sep 3, 2026 | $721.73K |
| Definium Therapeutics, Inc. DFTX | Award | Sep 2, 2026 | $0 |